Nothing Special   »   [go: up one dir, main page]

Pellá et al., 2020 - Google Patents

Chitosan hybrid microgels for oral drug delivery

Pellá et al., 2020

View HTML
Document ID
5550344510133842507
Author
Pellá M
Simão A
Lima-Tenório M
Tenório-Neto E
Scariot D
Nakamura C
Rubira A
Publication year
Publication venue
Carbohydrate polymers

External Links

Snippet

In the present work, hybrid microgels based on chitosan and SiO 2 nanoparticles (NPs) were synthesized. Both chitosan and the SiO 2 NPs were submitted to chemical modification reactions to having vinyl groups incorporated into their structures. The microgels were …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions or lattices by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions or lattices by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes

Similar Documents

Publication Publication Date Title
Pellá et al. Chitosan hybrid microgels for oral drug delivery
Zare et al. Recent progress in the industrial and biomedical applications of tragacanth gum: A review
Riegger et al. A systematic approach of chitosan nanoparticle preparation via emulsion crosslinking as potential adsorbent in wastewater treatment
Gan et al. Chitosan nanoparticle as protein delivery carrier—systematic examination of fabrication conditions for efficient loading and release
Lima et al. pH-responsive alginate-based hydrogels for protein delivery
Yang et al. Preparation and application of micro/nanoparticles based on natural polysaccharides
Moya-Ortega et al. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications
Ji et al. Engineering pectin-based hollow nanocapsules for delivery of anticancer drug
Anal et al. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin
Coviello et al. Polysaccharide hydrogels for modified release formulations
Fan et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique
Oh et al. Atom transfer radical polymerization in inverse miniemulsion: a versatile route toward preparation and functionalization of microgels/nanogels for targeted drug delivery applications
Maiti et al. Al+ 3 ion cross-linked and acetalated gellan hydrogel network beads for prolonged release of glipizide
Li et al. Quaternized chitosan/alginate nanoparticles for protein delivery
Dhanka et al. Methotrexate loaded gellan gum microparticles for drug delivery
Suner et al. Responsive biopolymer-based microgels/nanogels for drug delivery applications
Li et al. Self-assembled nanoparticles from thermo-sensitive polyion complex micelles for controlled drug release
Cruz et al. Radiation grafting of N-vinylcaprolactam onto nano and macrogels of chitosan: Synthesis and characterization
Mu et al. Fabrication of flocculation-resistant pH/ionic strength/temperature multiresponsive hollow microspheres and their controlled release
Chandrasekar et al. Characterization of nisin containing chitosan-alginate microparticles
Cho et al. Size-controlled self-aggregated N-acyl chitosan nanoparticles as a vitamin C carrier
Pellá et al. Magnetic chitosan microgels: Synthesis, characterization, and evaluation of magnetic field effect over the drug release behavior
Huang et al. Preparation of pH-and thermo-sensitive chitosan-PNIPAAm core–shell nanoparticles and evaluation as drug carriers
Di Martino et al. Chitosan grafted low molecular weight polylactic acid for protein encapsulation and burst effect reduction
Hesan et al. The synthesis and characterization of core-shell nanogels based on alginate and chitosan for the controlled delivery of mupirocin